AstriVax Therapeutics
Pioneering immune interventions to treat chronic disease
38 employees · est. 2022 · Belgium
IMUTEX Ltd
A joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the development of FLU-v & AGS-v
2 employees · est. 2016
IMUTEX Ltd is the older company (2022 vs 2016); AstriVax Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | AstriVax Therapeutics | IMUTEX Ltd |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2016 older |
| Headquarters | ||
| Headquarters | Belgium | Not tracked yet |
| Employees | ||
| Employees | 38 larger | 2 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Grant | Seed |
| Total Funding | ||
| Total Funding | $35.50M | $14.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Vaccinology, Vaccine Technology, DNA-based Technology, Live Attenuated Viruses, Infectious Diseases, Vaccine Development, Cold Chain Requirements, Broad-spectrum Protection, Pathogen Prevention, Clinical Validation, Vaccination Pipeline | Pharmaceuticals, Vaccines, Joint Venture, Public Health, Infectious Diseases, Vaccine Development, Partnership, Medical Research, CDC, NIH, NIAID, Influenza |
| Website | ||
| Website | astrivax.com | imutex.com |
About AstriVax Therapeutics
AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is committed to addressing real-world challenges in vaccinology by building a first-in-class Plug & Play vaccine platform with a patented DNA-based...
About IMUTEX Ltd
IMUTEX Ltd is a joint venture between SEEK Group and hVIVO, part of Open Orphan plc, established in 2016. The company's mission is to expedite the development of a Broad-Spectrum ‘Universal’ Influenza Vaccine, FLU-v, and a Mosquito-Borne Diseases Vaccine, AGS-v. These vaccines are identified as key...
We will tell you when either one moves
BounceWatch watches AstriVax Therapeutics and IMUTEX Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AstriVax Therapeutics and IMUTEX Ltd — by email.
Frequently Asked Questions
Compare AstriVax Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at AstriVax Therapeutics on 11 Sep 2024, and IMUTEX Ltd on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.